Showing 5681-5690 of 9806 results for "".
- Rocatinlimab Shows Promise in ADhttps://practicaldermatology.com/news/rocatinlimab-shows-promise-in-ad/2461465/Rocatinlimab—a novel, patient-tailored monoclonal antibody therapy—showed promising results in atopic dermatitis patients both while taking the drug and up to 20 weeks after the therapy was stopped, Mount Sinai researchers reported in
- Zubin Meshginpoosh Named President and COO at Sentéhttps://practicaldermatology.com/news/zubin-meshginpoosh-named-president-and-coo-at-sente/2461463/Zubin Meshginpoosh is now the President and Chief Operational Officer of Senté. "Zubin has an incredible track record for enabling teams to achieve success in high growth and fast-changing environments," says Faheem Hasnain, Chairman of the Board at Senté, in a n
- New Melanoma Immunotherapy Drugs Are Saving Liveshttps://practicaldermatology.com/news/new-melanoma-immunotherapy-drugs-are-saving-lives/2461462/New research suggest that the use of new pharmacological therapies is associated with a decrease in the melanoma mortality rate in the U.S. population. In the population-based cross-sectional study of patients with cutaneous melanoma from the Surveillance, Epidemiology, and E
- UCB’s Bimekizumab Performs Well in PsA Studieshttps://practicaldermatology.com/news/ucbs-bimekizumab-performs-well-in-psa-studies/2461460/Two new studies highlight the efficacy and safety of bimekizumab in the treatment of adults with active psoriatic arthritis who were biologic-naïve and/or tumor necrosis factor inhibitor inadequate responders (TNFi-IR). The 24-week results from the Phase 3 BE OPTIMAL study and 16-w
- American Hair Research Society to Host Hybrid Alopecia Areata Summit 12/10-11https://practicaldermatology.com/news/american-hair-research-society-to-host-hybrid-alopecia-areata-summit-1210-11/2461459/The Alopecia Areata Summit “New Pathways, New Treatments” organized by the American Hair Research Society will be held December 10-11 at the New York Academy of Medicine, 1216 5th Ave., New York, NY. The meeting is being co-Chaired by Angela M. Christiano, PhD, Columbia Univ
- Arcutis Enrolls First Patient in Phase 1b Alopecia Areata Study of ARQ-255https://practicaldermatology.com/news/arcutis-enrolls-first-patient-in-phase-1b-alopecia-areata-study-of-arq-255/2461458/The first subject has been enrolled in a Phase 1b study evaluating Arcutis’ ARQ-255, a topical suspension of ivarmactinib, a potent and specific janus kinase 1 (JAK1) inhibitor, for the treatment of alopecia areata. ARQ-255 has been specifically formulated with Arcutis’
- Study: Isolated Nail PsO Not Linked to Metabolic Syndrome Riskhttps://practicaldermatology.com/news/study-isolated-nail-psoriasis-not-linked-to-metabolic-syndrome-risk/2461456/Isolated nail psoriasis does not increase risk for metabolic syndrome, according to a letter to the editor in the Journal of the European Academy of Dermatology & Venereology. The analysis include
- Study: Eating Grapes May Protect Skin from UV Damagehttps://practicaldermatology.com/news/study-eating-grapes-may-protect-skin-from-uv-damage/2461452/Consuming grapes can protect against ultraviolet (UV) damage to the skin, according to a new study in Antioxidants. Folks showed increased resistance to sunburn after consuming 2 ¼ cups of grapes every day
- Cosmetic Surgery Forum 2022 Kicks Off in Nashvillehttps://practicaldermatology.com/news/cosmetic-surgery-forum-2022-kicks-off-in-nashville/2461451/Now in its 14th year, the 2022 Cosmetic Surgery Forum is once again taking Nashville by storm with new faculty members, a new roundtable, and exciting new topics along with the frank discussions, candor, and live demos that attendees have come to expect. “CSF 2022 is our be
- Galderma Sponsors 21st Annual SCOPE Miami Beach 2022 Art Showhttps://practicaldermatology.com/news/galderma-sponsors-21st-annual-scope-miami-beach-2022-art-show/2461447/Galderma is the exclusive aesthetic injectables sponsor of the 21st annual SCOPE Miami Beach 2022 art show. Galderma will be highlighting its aesthetics portfolio – Restylane, Dysport (abobotulinumtoxinA) and Sculptra – and hosting a variety of